Medications and the Risk of Sudden Cardiac Death

NCT00241800 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-06-05

No results posted yet for this study

Summary

To investigate a potential relationship between four different classes of non-cardiovascular drugs and the risk of sudden cardiac death.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Wayne Ray · Vanderbilt University Medical Center

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241800 on ClinicalTrials.gov